Log in or Sign up for Free to view tailored content for your specialty!
Hospital Medicine News
In ‘scientific close call,’ CDC director adds booster recommendation for HCWs
CDC Director Rochelle P. Walensky, MD, MPH, issued a statement late Thursday night endorsing her vaccine advisory committee’s recommendations — made earlier in the day — on which Americans should be eligible for COVID-19 booster shots.
WHO updates guidance on monoclonal antibody treatment for COVID-19
A WHO guideline panel has updated recommendations for monoclonal antibody treatment in its “living” guide on drugs for COVID-19. The guidelines are published in The BMJ.
Log in or Sign up for Free to view tailored content for your specialty!
Medical Education and Leadership, Part 6: Foreign Medical Grads in Leadership with Eduardo Mireles-Cabodevila, MD
Eduardo Mireles-Cabodevila, MD, is an internationally renowned "Guru of Mechanical Ventilation and Neuromuscular Disease." He is also a fearless leader in the ICU. In this episode, he shares his journey into medicine and how he developed the “10 commandments” of fellowship research.
Stem cell transplant recipients respond well to COVID-19 vaccination, study finds
Hematopoietic stem cell transplant recipients responded well to the Pfizer-BioNTech COVID-19 vaccine in a single-center study, with 83% having an antibody response after two doses, researchers reported in JAMA Network Open.
Study does not support probiotic use in certain critically ill patients
Critically ill patients who required mechanical ventilation and received the probiotic Lactobacillus rhamnosus GG were as likely to develop ventilator-associated pneumonia as those who received placebo, a randomized clinical trial showed.
FDA committee votes against blanket recommendation for COVID-19 vaccine boosters
The FDA’s Vaccines and Related Biological Products Advisory Committee, or VRBPAC, voted 16-2 on Friday afternoon not to recommend a booster dose of Pfizer-BioNTech’s messenger RNA COVID-19 vaccine to Americans aged 16 years and older.
Q&A: Monoclonal antibody combinations appear equally effective against COVID-19
In the largest comparative randomized trial of monoclonal antibody treatments for COVID-19, two regimens — bamlanivimab/etesevimab and casirivimab/imdevimab — were safe and appeared to be equally effective, according to a press release.
NIH allocates nearly $470 million for long COVID research
The NIH has allocated nearly $470 million to fund large-scale national studies of long COVID that it said could involve tens of thousands of patients.
Biden plan ‘pretty comprehensive’ but lacks direction on surveillance, testing, treatment
President Joe Biden announced a six-pronged plan last week to combat a national rise in COVID-19 cases brought on by the delta variant.
Follow-up care at specialized AKI clinic shows promise for reducing rehospitalizations
Patients who received follow-up care at a specialized clinic following AKI had a lower risk for rehospitalization than patients who received usual care, investigators from the University of Kentucky Medical Center found.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read